High serum prostate-specific antigen levels in the absence of prostate cancer in Middle-Eastern men: The clinician's dilemma

BJU International

Volumn 91, Issue 7, 2003, Pages 618-622

  Kehinde, E O ^a   Sheikh, M ^a   Mojimoniyi, O A ^a   Francis, I ^a   Anim, J T ^a   Nkansa Dwamena, D ^a   Al Awadi, K A ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Arabs; Caucasians; Diagnosis; Middle East; Prostate cancer; PSA

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARAB; ARTICLE; CALCIFICATION; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CANCER STAGING; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE MARKER; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROSTATISM; PROSTATITIS; RACE DIFFERENCE; RISK FACTOR; TRANSRECTAL ULTRASONOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ARABS; BIOPSY; HUMANS; MALE; MIDDLE AGED; MIDDLE EAST; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROSTATITIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 0038244787     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2003.04199.x     Document Type: Article

References (20)

1. Nadler RB, Humphrey PA, Smith DS et al. Effect of inflammation and BPH on elevated PSA levels. J Urol 1995; 154: 407-13
2. Catalona WJ, Miller DR, Kavoussi LR. Intermediate term survival results in clinically understaged prostate cancer patients following radical prostatectomy. J Urol 1988; 140: 540-3
3. Catalona WJ, Richie JP, Ahmaan FR et al. Comparison of digital rectal examination and serum PSA in the early detection of prostate cancer: results of a multicentre clinical trial of 6,630 men. J Urol 1994; 151: 1283-90
4. Schroder FH, Wildhagen MF. Screening for prostate cancer, evidence and perspective. BJU Int 2001; 88: 811-7
5. Christensson A, Bjork T, Nilsson O et al. Serum PSA complexed to alpha-1-anti-chymotrypsin as an indicator of prostate cancer. J Urol 1993; 150: 100-5
6. Memon A, Al-Muhanna AN. Annual cancer incidence in Kuwaitis 1992-93. In Parkin DM, Whelan SL, Ferlay J et al. eds. Cancer Incidence in Five Continents, Vol. VIII. no. 143. Lyons, France: IARC Scientific Publications, 1997: 410-7
7. Kehinde EO. Prostate cancer in the Middle East: Perspective from Oman. In Belldegrun A, Kirby RS, Oliver RTD eds. New Perspectives in Prostate Cancer. Oxford: ISIS Medical Media, 1998: 383-90
8. Hanash KA, Al-Othmaimen A, Kattan S et al. Prostatic carcinoma. A nutritional disease? Conflicting data from the Kingdom of Saudi Arabia. J Urol 1999; 161: 71
9. Anim JT, Udo S, John B. Characterisation of inflammatory cells in benign prostatic hyperplasia. Acta Histochem 1998; 100: 439-99
10. Nickel JC, True LD, Kreiger IN, Berger RE, Boag AH, Young ID. Consensus development of a histopathological classification system for chronic prostatic inflammation. BJU Int 2001; 87: 797-805
11. Selmy G. The value of TRUS in the ultrasonographic unit. Afr J Urol 1998; 4: 93-7
12. Toktas G, Unluer E, Aglamis E, Kulksizoglu H, Mimaroglu S. Effects of chronic prostatitis on prostate specific antigen. BJU Int 2000; 86 (Suppl. 3): 104
13. Tan YH, Tan KY, Foo KT. The role of a trial of antibiotics in asymptomatic patients with elevated prostate specific antigen - an Asian Perspective. BJU Int 2000; 86 (Suppl. 3): 104
14. Hasui Y, Marutsuka K, Asada Y, Ide H, Nishi S, Osada Y. Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia. The Prostate 1994; 25: 91-6
15. Dalton DL. Elevated serum prostate specific antigen due to acute bacterial prostatitis. Urology 1989; 33: 465-6
16. Neal DE Jr, Clejan S, Sarma D, Moon TD. Prostate specific antigen and prostatitis I. Effect of prostatitis on serum PSA in the human and non-human primate. The Prostate 1992; 20: 105-10
17. Anim JT, Ebrahim BH, Sathar SA. Benign disorders of the prostate: a histological study. Ann Saudi Med 1998; 18: 22-7
18. Stewart CS, Leibovich BC, Weaver AL, Lieber MA. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001; 166: 86-91
19. Stamey TA. Editorial comment: saturation prostate needle biopsy. J Urol 2001; 166: 91-2
20. Durgan JA, Bostwick DG, Myers RP et al. The definition and preoperative prediction of clinically insignificant prostate cancer JAMA 1996; 275: 288-94